Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 368

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 368
---
 extend the post-termination exercisability period of awards and to extend the maximum term of an option
or stock appreciation right (subject to the provisions of the 2022 Plan), to allow Participants to satisfy withholding tax obligations
in a manner permissible under the 2022 Plan, to authorize any person to execute on behalf of us any instrument required to effect the
grant of an award previously granted by the administrator and to allow a participant to defer the receipt of payment of cash or the delivery
of shares that would otherwise be due to such participant under an award. The administrator also has the authority to allow participants
the opportunity to transfer outstanding awards to a financial institution or other person or entity selected by the administrator and
to institute an exchange program by which outstanding awards may be surrendered or cancelled in exchange for awards of the same type
which may have a higher or lower exercise price or different terms, awards of a different type or cash, or by which the exercise price
of an outstanding award is increased or reduced. The administrator’s decisions, interpretations and other actions are final and
binding on all participants.

Eligibility

Awards under the 2022 Plan, other than incentive
stock options, may be granted to our employees (including our officers and directors) or a parent or subsidiary, members of our Board,
or consultants engaged to render bona fide services to us or a parent or subsidiary. Incentive stock options may be granted only to our
employees or a subsidiary, provided the services (i) are not in connection with the offer or sale of securities in a capital-raising
transaction, and (ii) do not directly promote or maintain a market for our securities, in each case, within the meaning of Form S-8 promulgated
under the Securities Act, and provided further, that a consultant will include only those persons to whom the issuance of shares may
be registered under Form S-8 promulgated under the Securities Act.

Stock Options

Stock options may be granted under the 2022 Plan.
The exercise price of options granted under the 2022 Plan generally must at least be equal to the fair market value of our common stock
on the date of grant. The term of each option will be as stated in the applicable award agreement; provided, however, that the term may
be no more than 10 years from the date of grant. The administrator will determine the methods of payment of the exercise price of an
option, which may include cash, shares or other property acceptable to